Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

White House Coverage

FDA Commissioner Marty Makary (L) and Secretary of Health and Human Services Robert F. Kennedy Jr (R) listen as Medicare and Medicaid Administrator Mehmet Oz speaks during a press briefing at the White House, Washington, DC, USA, 07 January 2026. The US government have released updated dietary guidelines for Americans. EPA/WILL OLIVER/POOL

E

White House Coverage

FDA Commissioner Marty Makary alongside, Medicare and Medicaid Administrator Mehmet Oz (L), Secretary of Health and Human Services Robert F. Kennedy Jr (C-R) Secretary of Agriculture Brooke Rollins (R) during a press briefing at the White House, Washington, DC, USA, 07 January 2026. The US government have released updated dietary guidelines for Americans. EPA/WILL OLIVER/POOL

E

White House Coverage

Secretary of Health and Human Services Robert F. Kennedy Jr speaks alongside Medicare and Medicaid Administrator Mehmet Oz (L) and Secretary of Agriculture Brooke Rollins (R) during a press briefing at the White House, Washington, DC, USA, 07 January 2026. The US government have released updated dietary guidelines for Americans. EPA/WILL OLIVER/POOL

E

White House Coverage

Medicare and Medicaid Administrator Mehmet Oz (C) speaks during a press briefing at the White House, Washington, DC, USA, 07 January 2026. The US government have released updated dietary guidelines for Americans. EPA/WILL OLIVER/POOL

E

White House Coverage

Secretary of Health and Human Services Robert F. Kennedy Jr speaks alongside Dr. Ben Carson, (L) FDA Commissioner Marty Makary (2-L), Medicare and Medicaid Administrator Mehmet Oz (C-R), Secretary of Agriculture Brooke Rollins (2-R) White House Press Secretary Karoline Leavitt (R) during a press briefing at the White House, Washington, DC, USA, 07 January 2026. The US government have released updated dietary guidelines for Americans. EPA/WILL OLIVER/POOL

E

White House Coverage

FDA Commissioner Marty Makary speaks alongside, Medicare and Medicaid Administrator Mehmet Oz (L), Secretary of Health and Human Services Robert F. Kennedy Jr (C-R) Secretary of Agriculture Brooke Rollins (R) during a press briefing at the White House, Washington, DC, USA, 07 January 2026. The US government have released updated dietary guidelines for Americans. EPA/WILL OLIVER/POOL

E

White House Coverage

Secretary of Health and Human Services Robert F. Kennedy Jr speaks alongside FDA Commissioner Marty Makary (L), Medicare and Medicaid Administrator Mehmet Oz (C-R), Secretary of Agriculture Brooke Rollins (R) during a press briefing at the White House, Washington, DC, USA, 07 January 2026. The US government have released updated dietary guidelines for Americans. EPA/WILL OLIVER/POOL

E

White House Coverage

Secretary of Health and Human Services Robert F. Kennedy Jr listens as Medicare and Medicaid Administrator Mehmet Oz speaks during a press briefing at the White House, Washington, DC, USA, 07 January 2026. The US government have released updated dietary guidelines for Americans. EPA/WILL OLIVER/POOL

E

White House Coverage

Medicare and Medicaid Administrator Mehmet Oz listens as Secretary of Health and Human Services Robert F. Kennedy Jr speaks during a press briefing at the White House, Washington, DC, USA, 07 January 2026. The US government have released updated dietary guidelines for Americans. EPA/WILL OLIVER/POOL

E

President Trump delivers remarks on lowering the prices of drugs and pharmaceuticals

Administrator of the Centers for Medicare & Medicaid Services Dr. Mehmet Oz (R) and US Secretary of Commerce Howard Lutnick (L) look on as US President Donald Trump, with pharmaceutical executives, delivers remarks on lowering the prices of drugs and pharmaceuticals during an announcement in the Roosevelt Room of the White House in Washington, DC, USA, 19 December 2025.

E

Trump Marijuana Executive Order Signing

Mehmet Oz, Administrator, Centers for Medicare and Medicaid Services (CMMS) looks at his notes as United States President Donald J Trump signs an executive order to “reschedule marijuana from a schedule one to a schedule three controlled substance with legitimate medical uses” in the Oval Office of the White House in Washington, DC, USA, on Thursday, December 18, 2025. Credit: Aaron Schwartz / Pool via CNP

E

Trump Marijuana Executive Order Signing

Mehmet Oz, Administrator, Centers for Medicare and Medicaid Services (CMMS) gives remarks as United States President Donald J Trump signs an executive order to “reschedule marijuana from a schedule one to a schedule three controlled substance with legitimate medical uses” in the Oval Office of the White House in Washington, DC, USA, on Thursday, December 18, 2025. Credit: Aaron Schwartz / Pool via CNP

E

Trump Marijuana Executive Order Signing

Mehmet Oz, Administrator, Centers for Medicare and Medicaid Services (CMMS) gives remarks as United States President Donald J Trump signs an executive order to “reschedule marijuana from a schedule one to a schedule three controlled substance with legitimate medical uses” in the Oval Office of the White House in Washington, DC, USA, on Thursday, December 18, 2025. Credit: Aaron Schwartz / Pool via CNP

E

Trump Marijuana Executive Order Signing

Mehmet Oz, Administrator, Centers for Medicare and Medicaid Services (CMMS) gives remarks as United States President Donald J Trump signs an executive order to “reschedule marijuana from a schedule one to a schedule three controlled substance with legitimate medical uses” in the Oval Office of the White House in Washington, DC, USA, on Thursday, December 18, 2025. Credit: Aaron Schwartz / Pool via CNP

E

Trump Marijuana Executive Order Signing

Mehmet Oz, Administrator, Centers for Medicare and Medicaid Services (CMMS) gives remarks as United States President Donald J Trump signs an executive order to “reschedule marijuana from a schedule one to a schedule three controlled substance with legitimate medical uses” in the Oval Office of the White House in Washington, DC, USA, on Thursday, December 18, 2025. Credit: Aaron Schwartz / Pool via CNP

E

Trump Marijuana Executive Order Signing

Mehmet Oz, Administrator, Centers for Medicare and Medicaid Services (CMMS) gives remarks as United States President Donald J Trump signs an executive order to “reschedule marijuana from a schedule one to a schedule three controlled substance with legitimate medical uses” in the Oval Office of the White House in Washington, DC, USA, on Thursday, December 18, 2025. Credit: Aaron Schwartz / Pool via CNP

E

Trump Marijuana Executive Order Signing

Mehmet Oz, Administrator, Centers for Medicare and Medicaid Services (CMMS) makes remarks as United States President Donald J Trump signs an executive order to “reschedule marijuana from a schedule one to a schedule three controlled substance with legitimate medical uses” in the Oval Office of the White House in Washington, DC, USA, on Thursday, December 18, 2025. Credit: Aaron Schwartz / Pool via CNP

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

A man faints as US President Donald Trump gives remarks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

A man faints as US President Donald Trump gives remarks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

A man faints as US President Donald Trump gives remarks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

A man faints as US President Donald Trump gives remarks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

A man faints as US President Donald Trump gives remarks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

A man faints as US President Donald Trump gives remarks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

US President Donald Trump in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

Robert F. Kennedy Jr., US secretary of Health and Human Services (HHS), left, and Martin Makary, commissioner of the Food and Drug Administration (FDA), in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

US President Donald Trump in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

US President Donald Trump in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

A man faints as US President Donald Trump gives remarks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

Mike Doustdar, chief executive officer of Novo Nordisk A/S, in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

US President Donald Trump in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

A man faints as US President Donald Trump gives remarks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

A man faints as US President Donald Trump gives remarks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

Mike Doustdar, chief executive officer of Novo Nordisk A/S, in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

Representative Tom Emmer, a Republican from Minnesota, from left, US President Donald Trump, and Heidi Overton, White House domestic policy council, in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

Martin Makary, commissioner of the Food and Drug Administration (FDA), in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, from left, David Ricks, chief executive officer of Eli Lilly & Co., and Martin Makary, commissioner of the Food and Drug Administration (FDA), in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

David Moore, executive vice president of US Operations at Novo Nordisk A/S, in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

Heidi Overton, White House domestic policy council, in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

US President Donald Trump in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

Chris Klomp, deputy administrator of the Centers for Medicare and Medicaid, speaks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, speaks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

US President Donald Trump applauds in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

US President Donald Trump in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Trump Speaks in The Oval Office - Washington

US President Donald Trump in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Trump Speaks in The Oval Office - Washington

Howard Lutnick, US commerce secretary, and US President Donald Trump in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Trump Speaks in The Oval Office - Washington

Martin Makary, commissioner of the Food and Drug Administration (FDA), in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Trump Speaks in The Oval Office - Washington

Mike Doustdar, chief executive officer Novo Nordisk A/S, from left, David Ricks, chief executive officer of Eli Lilly & Co., and Howard Lutnick, US commerce secretary, stand behind US President Donald Trump in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Trump Speaks in The Oval Office - Washington

Robert F. Kennedy Jr., US secretary of Health and Human Services (HHS), speaks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Trump Speaks in The Oval Office - Washington

Mike Doustdar, chief executive officer Novo Nordisk A/S, in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM